Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor.

× No keyword cloud information.

29 in total

1. Chromenopyrazoles: non-psychoactive and selective CB₁ cannabinoid agonists with peripheral antinociceptive properties.

Authors: Jose Cumella; Laura Hernández-Folgado; Rocio Girón; Eva Sánchez; Paula Morales; Dow P Hurst; Maria Gómez-Cañas; Maria Gómez-Ruiz; Diana C G A Pinto; Pilar Goya; Patricia H Reggio; María Isabel Martin; Javier Fernández-Ruiz; Artur M S Silva; Nadine Jagerovic
Journal: ChemMedChem Date: 2012-02-02 Impact factor: 3.466

Review 2. Effects of Cannabinoids on T-cell Function and Resistance to Infection.

Authors: Toby K Eisenstein; Joseph J Meissler
Journal: J Neuroimmune Pharmacol Date: 2015-04-16 Impact factor: 4.147

3. The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoids.

Authors: Peter J Crocker; Anu Mahadevan; Jenny L Wiley; Billy R Martin; Raj K Razdan
Journal: Bioorg Med Chem Lett Date: 2007-01-13 Impact factor: 2.823

Review 4. Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands.

Authors: A Poso; J W Huffman
Journal: Br J Pharmacol Date: 2007-11-05 Impact factor: 8.739

5. Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.

Authors: John W Huffman; Alicia L S Thompson; Jenny L Wiley; Billy R Martin
Journal: Bioorg Med Chem Date: 2007-09-22 Impact factor: 3.641

6. Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.

Authors: Joong-Youn Shim; Alexander C Bertalovitz; Debra A Kendall
Journal: J Biol Chem Date: 2011-07-27 Impact factor: 5.157

Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor.

1. Chromenopyrazoles: non-psychoactive and selective CB₁ cannabinoid agonists with peripheral antinociceptive properties.

Review 2. Effects of Cannabinoids on T-cell Function and Resistance to Infection.

3. The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoids.

Review 4. Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands.

5. Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.

6. Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.

7. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.

8. Synthesis and pharmacology of 1-methoxy analogs of CP-47,497.

Review 9. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.

Review 10. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.